Vitasora Health Limited · ASX:VHL
Vitasora Health — Corporate Update (October 2026)
21 slides from Vitasora Health's corporate update, Oct 6, 2026
Slide 1: Vitasora: The Model is Built. It Works. Now We Scale.
ASX ANNOUNCEMENT ASX:VHL OTCQB:VHLUF 6th October 2026 Vitasora: The Model is Built. It Works. Now We Scale. Vitasora Health Limited (ASX: VHL; OTCQB: VHLUF) (“Vitasora” or “the Company”) is pleased to provide the attached October 2026 Market Update, together with an investor presentation conducted b
Slide 2: ASX Announcement: About Vitasora and forward-looking statements
ASX ANNOUNCEMENT ASX:VHL OTCQB:VHLUF chronic disease management, ensuring patients' healthcare needs are met consistently and effectively across the continuum of care. Learn more at www.vitasorahealth.com.au About the wheezo® Medical Device wheezo®, a world-first FDA-approved Class II medical device
Slide 3: The Model is Built; it works. Now We Scale.
M A R K E T U P D AT E The Model is Built; it works. Now We Scale. More patients. More productive capacity. More revenue per patient. More Coordinators. A clear path to breakeven. CARE BEYOND THE CL INIC · Octo ber 2 0 2 6 · ASX: VHL
Slide 4: Important notice & disclaimer
IM P ORTANT NOTICE Important notice & disclaimer This presentation has been prepared by Vitasora Health Limited (ASX: VHL) (“Vitasora” or “the Company”) to provide a market update. It is general information only, does not take into account the investment objectives, financial situation or needs of a
Slide 5: The Operating Model is Built. The Patients are There. Now We Scale Capacity
INVESTM ENT THESIS The Operating Model is Built. The Patients are There. Now We Scale Capacity to Capture the Opportunity. 01 02 03 PATIENTS ARE ALREADY THERE THE MODEL IS WORKING GROWTH IS BECOMING FTE-LED Existing clients provide substantial patient populations vCare, workflow redesign and managem
Slide 6: The Model is Built & Delivering. More Capacity Now Drives More Revenue
EXECUTIVE SUM M ARY The Model is Built & Delivering. More Capacity Now Drives More Revenue US$382K US$1,028K US$17.4K 32 to 115 Sept exit rate a month (est) Sept Qtr ’26 revenue* (est), incl. September exit rate average with Productive CCs → 115 target, Q1 other revenue 29-32 CCs operating. High $18
Slide 7: Execution is now focused on growing & converting capacity into revenue growth
EXECUTION P RIORITIES Execution is now focused on growing & converting capacity into revenue growth With the operating platform established, patient demand available and a strong sales pipeline, management is focused on three levers that directly drive revenue and operating leverage. INVESTOR TAKEAW
Slide 8: Adding productive Care Coordinators drives the next revenue step-up
EXECUTION · CAP ACITY Adding productive Care Coordinators drives the next revenue step-up The September bar is the exit (four-day average, 25–30 Sep) plus assumed RPM; the later bars show estimated daily capacity once employed and planned CCs are productive. +6 CCs +9 CCs ~US$29.1K/day ~US$23.4K/day
Slide 9: The Revenue Engine is Scaling; Sept Qtr Revenue US$1,028K, up 38% (est)
FINANCIAL P ERFORM ANCE The Revenue Engine is Scaling; Sept Qtr Revenue US$1,028K, up 38% (est) The model is driving revenue $2,000K FFS +32% on June Qtr As lodged ← → Estimated revenue (not Estimate Illustrative exit rate, not $1,800K accounting) a forecast September exit materially higher $1,600K
Slide 10: The Operating Engine is Accelerating
01 OP ERATING P ERFORM ANCE The Operating Engine is Accelerating More patients. More productive capacity. Higher utilisation. More revenue per patient. Vitasora Health Limited · Market Update · October 2026 8
Slide 11: More Productive CCs = More Revenue Capacity
OP ERATING P ERFORM ANCE · CARE COORD INATORS More Productive CCs = More Revenue Capacity FTE ← → Headcount · plan · target ~US$560 care value a day 120 115 per productive CC at the September exit rate 100 80 • 32 productive CCs at the September exit: 39 employed, including those in training, who de
Slide 12: vCare is Doing What We Built It to Do: Driving More Productive Care at Scale
OP ERATING P ERFORM ANCE · CARE M INUTES vCare is Doing What We Built It to Do: Driving More Productive Care at Scale RPM migration: Jul–Aug 14,000 +26% on Sept Care minutes nearly 3× since launch 12,000 average minutes Exit rate 26% above September 10,000 average 8,000 • vCare is delivering: 2.9K c
Slide 13: Daily Revenue Activity Up 2.4× in a Year; Sept Exit Rate ~US$17.4K a Day
OP ERATING P ERFORM ANCE · D AIL Y ACTIVITY Daily Revenue Activity Up 2.4× in a Year; Sept Exit Rate ~US$17.4K a Day RPM migration: Jul–Aug Billed FFS ← → Estimated revenue $22,000 The Model is working & Accelerating. $20,000 Daily activity up 2.4× in 12 months September exit another 29% higher $18,
Slide 14: We Modelled CPT Codes. Our Patient Engagement Model Has Blown Through That.
OP ERATING P ERFORM ANCE · CARE INTENSITY We Modelled 2 CPT Codes. Our Patient Engagement Model Has Blown Through That. All CPT codes ← → Care CPTs (est) 2.5 Engagement is beating the model. More care. More CPT codes. More 2.13 revenue per patient. 2.0 1.83 1.76 1.71 • 1.83 CPT codes per billed pati
Slide 15: Satisfied clients provide the patients: enrolment activity of 796 in September
OP ERATING P ERFORM ANCE · L EAD ING IND ICATOR Satisfied clients provide the patients: enrolment activity of 796 in September 3,000 Existing clients are driving accelerating enrolments. 2,500 2,388 September pace: ~2,400 per quarter 2,000 1,596 • All enrolment activity is from existing clients’ 1,4
Slide 16: New Management and System Have Lifted Utilisation. Now We Add Capacity.
OP ERATING P ERFORM ANCE · UTIL ISATION New Management and System Have Lifted Utilisation. Now We Add Capacity. ← Revenue per FTE Care minutes → 120% We fixed productivity. 360-minute daily target (100%) 100% Now we scale it 90%+ 80% 32 CCs 67% • Per FTE / CC: 67% (Mar Qtr ’26, revenue method) → 20
Slide 17: Services deliver quality outcomes that are valued by clients and patients
02 CL INICAL OUTCOM ES Services deliver quality outcomes that are valued by clients and patients Vitasora Health Limited · Market Update · October 2026 15
Slide 18: The Vitasora Difference: We Don’t Just Collect Data. We Act on It.
The Vitasora Difference: We Don’t Just Collect Data. We Act on It. Skilled Care Coordinators turn patient data into engagement, behaviour change and measurable outcomes — while generating reimbursable care. 8.5 points lower systolic 70% of these patients got better 35% back in the controlled range 3
Slide 19: Scaling to sustained operational break-even
THE NEXT PHASE Scaling to sustained operational break-even The platform is built. The patients are available. Next: add productive capacity, lift the daily rate and sustain it for a full month to reach operational break-even. 01 02 03 04 05 SCALE CAPACITY FILL THE CAPACITY GROW VALUE / PATIENT CLOSE
Slide 20: Thank you
Thank you For further information, investors and media please contact: Mr Marjan Mikel Mr Nicholas Smedley CEO & Managing Director Non-Executive Chairman Vitasora Health Limited Vitasora Health Limited P: +61 408 462 873 P: +61 447 074 160 E: marjan@vitasorahealth.com E: nicholas@vitasorahealth.com
Slide 21: Basis of preparation
BASIS OF P REP ARATION Basis of preparation Reporting period and status. Operating data cover the September quarter to 30 September 2026 (September: 21 operating days). Estimated revenue comes from care- activity records; UPEC from the USA management P&L (September: the July–August average); other r